SLC44A2 and colorectal carcinoma: As shown in Fig. 5D, SLC44A2 overexpression significantly shortened the half-life of CPT2 in HCT116 cells, while SLC44A2 knockdown extended it in HT29 cells, indicating that SLC44A2 promotes CPT2 degradation in CRC cells.